Adverse Event Reporting News - FDA reviewing safety of Merck, Mylan drugs
Sunday, January 4th, 2009 FDA March 27 announced it is investigating a possible link between suicidal behavior and the use of several popular asthma drugs, including Merck’s Singulair and Mylan Laboratories’ Zyflo.
Singulair is a medicine in the drug class known as leukotriene receptor antagonists, used to treat asthma and the symptoms of allergic rhinitis (sneezing, stuffy nose, runny nose, itching of the nose) and to prevent exercise-induced asthma.
Ov…
